Cargando…
SARS-CO-V2 ANTIBODY STATUS IN CHILDREN WITH MITOCHONDRIAL DISEASE
Autores principales: | Thompson, Elizabeth, Gordon-Lipkin, Eliza, Kruk, Shannon, McGuire, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931938/ http://dx.doi.org/10.1016/j.ymgme.2022.01.094 |
Ejemplares similares
-
VACCINE HESITANCY TOWARD THE COVID19 VACCINE AND ATTITUDES TOWARD RING VACCINATION BY CAREGIVERS OF CHILDREN WITH MITOCHONDRIAL DISEASE
por: Gordon-Lipkin, Eliza, et al.
Publicado: (2022) -
RISK MITIGATION BEHAVIORS TO PREVENT INFECTION IN THE MITOCHONDRIAL DISEASE COMMUNITY DURING THE COVID19 PANDEMIC
por: Gordon-Lipkin, Eliza, et al.
Publicado: (2022) -
Short report: Vaccine attitudes in the age of COVID-19 for a population of children with mitochondrial disease()()
por: Gordon-Lipkin, Eliza, et al.
Publicado: (2022) -
RISK FACTORS FOR EXPOSURE AND MORBIDITY ASSOCIATED WITH COVID19 IN THE MITOCHONDRIAL DISEASE POPULATION
por: Kruk, Shannon, et al.
Publicado: (2022) -
Undiagnosed COVID-19 in households with a child with mitochondrial disease
por: Gordon-Lipkin, Eliza M., et al.
Publicado: (2022)